Batches of Novo Nordisk insulin face European recall
LONDON Oct 25 (Reuters) - The European Medicines Agency said on Friday that some batches of Novo Nordisk's insulin products NovoMix 30 FlexPen and Penfill were being recalled because they might contain the wrong amount of insulin.
Due to a manufacturing problem during the filling of the cartridges, some contained too many or too few insulin units per millilitre, it said.
Only a very small proportion of cartridges - 0.14 percent - contain a wrong amount but in those affected the level of insulin may vary between 50 percent and 150 percent of the labelled dose.
The EU regulator said patients using products from the affected batches should be switched to supplies from unaffected batches or alternative treatments.
(Reporting by Ben Hirschler; editing by Clara Marques)
- Tweet this
- Share this
- Digg this
- Malaysia Airlines plane missing at sea off Vietnam, presumed crashed
- Hollywood blockbuster 'Noah' faces ban in Arab world
- IndiGo plane evacuated after rear wheel catches fire in Nepal
- CORRECTED-UPDATE 4-Malaysia Airlines plane crashes in South China Sea with 239 people aboard - report
- UPDATE 3-U.S. FDA probes cognitive impact of new cholesterol drugs